Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage
- 1 June 1983
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 2 (3) , 253-259
- https://doi.org/10.1007/bf02029528
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprimAntimicrobial Agents and Chemotherapy, 1982
- Norfloxacin and the antibacterial γ pyridone β carboxylic acidsJournal of Antimicrobial Chemotherapy, 1982
- Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolatesAntimicrobial Agents and Chemotherapy, 1982
- Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatographyAntimicrobial Agents and Chemotherapy, 1982
- In vitro antibacterial activity of norfloxacin (MK-0366)Antimicrobial Agents and Chemotherapy, 1982
- Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agentsInfection, 1982
- Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeaeAntimicrobial Agents and Chemotherapy, 1981
- Comparative Activities of AM-715 and Pipemidic and Nalidixic Acids Against Experimentally Induced Systemic and Urinary Tract InfectionsAntimicrobial Agents and Chemotherapy, 1981
- In Vitro Antibacterial Activity of AM-715, a New Nalidixic Acid AnalogAntimicrobial Agents and Chemotherapy, 1980